mammalian
defensin
cation
peptid
compris
subfamili
denot
defensin
contribut
host
defens
antimicrobi
agent
regul
inflammatori
adapt
immun
respons
similar
topolog
differ
disulfid
linkag
macrocycl
peptid
express
old
world
monkey
eg
macaqu
baboon
known
cyclic
protein
anim
backbon
produc
splice
nonapeptid
excis
precursor
rhesu
macaqu
altern
binari
splice
nonapeptid
encod
precursor
gene
give
rise
isoform
baboon
altern
nonapeptid
splice
produc
isoform
express
high
level
granul
neutrophil
monocyt
abund
macaqu
constitut
total
content
rhesu
neutrophil
major
role
antimicrobi
activ
rhesu
extract
human
hominid
lack
stop
codon
sequenc
gene
speci
suggest
express
old
world
monkey
underli
differ
immun
inflammatori
respons
nonhuman
primat
human
although
discov
base
antimicrobi
properti
subsequ
studi
disclos
immun
regulatori
role
peptid
exampl
chemotact
cell
neutrophil
dendrit
cell
monocyt
induc
secret
proinflammatori
cytokin
activ
dendrit
cell
peripher
blood
mononuclear
cell
epitheli
cell
contrast
proinflammatori
activ
recent
report
properti
vitro
vivo
potent
inhibitor
cytokin
secret
human
peripher
blood
leukocyt
stimul
divers
tlr
agonist
natur
occur
isoform
rtd
possess
variabl
potenc
suppress
tnf
express
escherichia
leukocyt
suppress
inflammatori
cytokin
includ
sever
chemokin
mous
model
sever
acut
respiratori
syndrom
corona
viru
infect
e
coli
periton
polymicrobi
sepsi
effect
strongli
correl
reduc
mortal
model
result
suggest
modul
inflamm
via
regul
pathway
share
divers
inflammatori
stimuli
identifi
regulatori
pathway
mediat
novel
macrocycl
peptid
analyz
effect
stimul
macrophag
human
monocyt
evalu
effect
peptid
cytokin
express
secret
signal
transduct
pathway
involv
inflammatori
respons
pma
marimastat
pmsf
sigma
chemic
co
st
loui
mo
usa
e
coli
lp
quantiblu
invivogen
san
diego
ca
usa
mapk
pan
ab
cell
signal
technolog
danver
usa
marimastat
cell
signal
technolog
solut
prepar
dmso
cell
signal
technolog
suspend
pb
contain
hi
fb
synthet
hydrochlorid
prepar
describ
previous
human
purifi
neutrophil
stock
solut
peptid
prepar
steril
acet
acid
blood
collect
healthi
donor
prior
written
consent
accord
protocol
approv
univers
southern
california
institut
review
board
approv
number
monocyt
atcc
manassa
va
usa
cultur
rpmi
fb
ps
dual
cell
invivogen
express
report
seap
grown
rpmi
antibiot
cell
differenti
induc
treatment
cell
cellsml
nm
pma
cultur
cell
invivogen
grown
dmem
medium
contain
ps
normocin
cell
cultur
cell
cell
cultur
plate
wash
twice
complet
medium
grown
fresh
medium
contain
fb
h
cell
wash
twice
fresh
medium
incub
h
manipul
cell
stimul
ngml
lp
presenc
absenc
vehicl
acet
acid
h
experi
cell
first
incub
h
marimastat
vehicl
dmso
lp
ad
incub
h
peripher
blood
monocyt
lonza
walkersvil
md
usa
thaw
rins
rpmi
medium
contain
hi
fb
ps
normocin
resuspend
rpmi
medium
contain
hi
fb
plu
antibiot
cellsml
h
cell
stimul
h
describ
fig
medium
collect
clarifi
centrifug
first
g
min
g
min
quantifi
elisa
life
technolog
carlsbad
ca
usa
differenti
cell
treat
lp
h
wash
pb
rna
isol
use
rna
mini
kit
zymo
research
irvin
ca
usa
rneasi
mini
kit
qiagen
valencia
ca
usa
rna
integr
confirm
agaros
gel
rna
sampl
ratio
use
gener
cdna
brief
ng
rna
incub
gdna
elimin
buffer
min
revers
transcrib
use
first
strand
synthesi
kit
qiagen
custom
pcr
array
sa
bioscienc
frederick
md
usa
contain
human
gene
interest
control
revers
transcriptas
pcr
effici
rtc
ppc
respect
use
simultan
pcr
analysi
master
mix
contain
cdna
sybr
green
ad
array
well
pcr
cycl
paramet
cycl
min
cycl
min
thermal
cycler
laboratori
hercul
ca
usa
equip
system
melt
curv
analysi
confirm
singl
amplicon
ct
ppc
sampl
actb
gene
use
normal
gene
express
fold
stimul
compar
untreat
cell
calcul
use
method
absenc
gdna
cdna
sampl
ct
confirm
use
human
gdna
primer
sa
bioscienc
aliquot
ml
dual
cell
cellsml
tissu
cultur
plate
starv
complet
medium
hi
fb
describ
experi
peptid
ml
cultur
plate
use
fresh
medium
contain
hi
fb
ad
cell
h
cell
stimul
ngml
lp
ngml
presenc
acet
acid
vehicl
experi
cell
preincub
marimastat
vehicl
h
addit
lp
follow
overnight
incub
medium
clarifi
centrifug
seap
activ
determin
use
quantiblu
reagent
measur
absorb
nm
test
effect
activ
cellsml
cultur
plate
stimul
overnight
without
medium
harvest
seap
activ
assay
use
quantiblu
activ
defin
fold
stimul
seap
activ
compar
control
cell
nuclear
extract
prepar
nuclear
extract
kit
cayman
chemic
co
ann
arbor
mi
usa
differenti
cell
treat
min
vehicl
lp
ngml
ngml
presenc
absenc
dna
bind
quantifi
elisa
cayman
chemic
nonspecif
extract
extract
treat
competitor
dna
control
includ
elisa
use
confirm
specif
blood
incub
human
monocyt
enrich
cocktail
stemcel
technolog
vancouv
bc
canada
min
layer
sepmat
tube
stem
cell
technolog
cell
centrifug
g
min
layer
cell
isol
wash
pb
contain
hi
fb
mm
edta
differenti
cell
ml
medium
starv
complet
medium
contain
fb
fresh
ml
rpmi
fb
ps
ad
h
experi
fresh
monocyt
cell
resuspend
cellsml
medium
promocel
heidelberg
germani
plate
h
cell
wash
time
rpmi
medium
contain
hi
fb
suspend
overnight
rpmi
medium
contain
hi
fb
cell
stimul
agonist
without
describ
figur
legend
cell
wash
pb
extract
prepar
cell
lysi
buffer
mm
pmsf
protein
content
determin
use
bicinchonin
acid
method
extract
resolv
gel
transfer
nitrocellulos
membran
membran
probe
indic
antibodi
develop
use
secondari
antibodi
detect
chemiluminesc
phosphoprotein
antibodi
array
r
system
minneapoli
mi
usa
use
analyz
activ
phosphoprotein
kinas
differenti
cell
cell
treat
ngml
lp
ngml
lp
vehicl
min
array
probe
protein
chemiluminesc
spot
array
band
western
blot
quantifi
use
us
nation
institut
health
imagej
softwar
bethesda
md
usa
background
subtract
normal
plot
sd
sem
calcul
experi
repeat
time
respect
student
test
perform
evalu
signific
peptid
effect
indic
figur
legend
differ
consid
signific
p
microsoft
redmond
wa
usa
excel
use
statist
analys
previou
studi
found
suppress
secret
sever
inflammatori
cytokin
peripher
blood
leukocyt
stimul
agonist
tlr
inhibit
releas
notabl
studi
treatment
markedli
suppress
secret
primari
human
monocyt
macrophag
fig
alon
effect
cytokin
secret
fig
consist
previou
find
cytokin
inhibitori
effect
macrophag
close
resembl
respons
obtain
buffi
coat
cell
human
monocyt
indic
cell
provid
appropri
model
dissect
mechan
experi
similar
describ
figur
analyz
effect
cytokin
mrna
express
cell
focus
cytokin
suppress
treatment
blood
leukocyt
shown
fig
markedli
inhibit
mrna
express
cytokin
addit
effect
express
gapdh
peptid
alon
effect
cytokin
mrna
express
result
fig
demonstr
potent
regul
proinflammatori
cytokin
express
releas
macrophag
given
central
role
signal
inflamm
hypothes
modul
pathway
cell
stimul
differ
tlr
agonist
lp
agonist
treatment
cell
induc
activ
fig
simultan
treatment
lp
suppress
activ
wherea
alon
effect
fig
addit
direct
effect
enzymat
activ
seap
report
fig
inhibit
activ
dose
depend
fig
noteworthi
inhibit
activ
observ
equimolar
concentr
human
neutrophil
fig
acycl
variant
fig
use
place
test
effect
activ
induc
stimuli
analyz
respons
cell
stimul
agonist
hek
blue
cell
stimul
agonist
without
addit
ligand
stimul
activ
respect
addit
inhibit
activ
peptid
suppress
activ
baselin
level
fig
e
respect
character
effect
cell
analyz
effect
peptid
dna
bind
lp
treatment
induc
increas
dna
bind
fig
howev
coincub
lp
reduc
dna
bind
baselin
level
fig
correl
level
subunit
level
nuclear
extract
cell
treat
lp
detect
western
blot
fig
also
test
effect
stimul
dna
bind
compar
alon
suppress
dna
bind
substanti
less
inhibit
observ
cell
decreas
inhibit
dna
bind
correl
level
nuclear
extract
treat
untreat
cell
fig
effect
compar
marimastat
potent
inhibitor
convert
enzym
sheddas
produc
solubl
precursor
marimastat
effici
block
releas
cell
affect
secret
fig
result
contrast
inhibitori
activ
block
cytokin
effect
fig
also
marimastat
treatment
effect
activ
fig
contrast
potent
inhibitor
presenc
absenc
marimastat
fig
lp
bind
initi
cascad
signal
event
lead
activ
complex
contain
phosphoryl
ikk
activ
ikk
phosphoryl
inhibitor
trigger
degrad
activ
nuclear
transloc
fig
activ
also
stimul
numer
kinas
pathway
effect
block
degrad
macrophag
accompani
inhibit
mapk
phosphoryl
alon
effect
level
phosphoryl
mapk
fig
use
phosphoprotein
antibodi
array
identifi
potenti
signal
target
extract
macrophag
contain
elev
level
phosphoryl
creb
compar
control
cell
fig
inhibit
phosphoryl
protein
baselin
level
fig
lower
panel
treatment
alon
suppress
phosphoryl
protein
fig
contrast
alon
combin
lp
stimul
phosphoryl
fig
kinet
effect
akt
express
phosphoryl
determin
treat
cell
alon
vehicl
analyz
akt
pakt
level
treatment
induc
increas
pakt
within
min
peptid
treatment
pakt
level
remain
elev
least
h
fig
addit
experi
perform
identifi
role
observ
stimul
akt
phosphoryl
addit
inhibitor
markedli
reduc
pakt
level
fig
demonstr
effect
upstream
akt
pathway
neg
regul
activ
mapk
pathway
test
effect
inhibit
activ
dual
macrophag
cell
revers
suppress
activ
manner
fig
evid
stimul
akt
phosphoryl
contribut
observ
effect
next
test
effect
signal
pathway
primari
human
monocyt
alon
induc
degrad
reduc
degrad
monocyt
fig
inhibit
mapk
phosphoryl
monocyt
peptid
alon
effect
mapk
phosphoryl
fig
howev
observ
experi
macrophag
increas
phosphoryl
akt
observ
monocyt
treat
lp
lp
alon
compar
control
cell
fig
thu
similarli
regul
mapk
signal
pathway
human
blood
monocyt
cell
studi
reveal
pleiotrop
properti
macrocycl
molecul
initi
isol
base
antibacteri
antifung
properti
vitro
subsequ
studi
demonstr
broader
properti
mediat
antivir
properti
herp
simplex
viru
hiv
influenza
arm
phagocyt
enhanc
kill
bacillu
anthraci
also
studi
reveal
protect
effect
system
administ
mous
model
sever
acut
respiratori
syndrom
coronaviru
infect
sepsi
mediat
least
partli
suppress
immunopatholog
cytokin
express
gain
insight
immunomodulatori
mechan
mediat
analyz
effect
inflammatori
pathway
macrophag
inhibit
secret
sever
proinflammatori
cytokin
human
buffi
coat
cell
stimul
e
coli
cell
well
agonist
particularli
mark
suppress
consist
find
concentr
previous
found
effect
block
tnf
secret
stimul
blood
cell
highli
effect
block
secret
cell
human
monocyt
fig
bind
ineffici
lp
immun
regulatori
effect
mediat
neutral
lp
also
show
suppress
cytokin
correspond
correspond
mrna
level
indic
first
time
knowledg
previous
observ
mechan
mediat
regul
inflammatori
gene
express
well
note
alon
affect
cytokin
mrna
protein
level
unstimul
cell
fig
stimul
inflammatori
gene
express
divers
tlr
agonist
due
activ
pathway
repress
cytokin
stimul
sever
tlr
agonist
analyz
effect
peptid
treatment
activ
cell
treat
lp
agonist
tlr
cell
surfac
respect
cell
stimul
agonist
intracellular
treatment
markedli
inhibit
activ
agonist
fig
inhibitori
effect
dose
depend
consist
find
inhibit
transloc
nucleu
macrophag
fig
stabil
fig
human
inhibitori
activ
fig
agreement
previou
report
human
neutrophil
lack
properti
noteworthi
acycl
version
fig
inhibit
activ
demonstr
cyclic
structur
peptid
essenti
activ
previous
show
blockad
secret
e
whole
blood
extrem
rapid
suggest
blockad
numer
cytokin
result
cytokin
express
show
reduc
activ
cell
fig
lesser
extent
peptid
effect
lp
stimul
fig
consist
result
suppress
secret
cell
mark
contrast
marimastat
fig
potent
inhibitor
sheddas
gener
solubl
inhibit
releas
fig
thu
blockad
releas
subsequ
suppress
autocrin
signal
alon
account
immunomodulatori
effect
also
analyz
effect
signal
kinas
implic
inflammatori
respons
macrophag
inhibit
phosphoryl
sever
inflammatori
signal
protein
includ
jnk
creb
fig
inhibit
creb
phosphoryl
consist
suppress
mapk
phosphoryl
protein
fig
mapk
also
implic
stabil
mrna
contain
element
includ
sever
immun
respons
gene
pathway
involv
nucleocytoplasm
transport
mrna
mous
macrophag
cell
stimul
jnk
mapk
lead
activ
class
transcript
factor
involv
activ
immun
respons
gene
thu
appear
regul
inflammatori
signal
inhibit
phosphoryl
sever
inflammatori
signal
protein
cell
exposur
alon
induc
phosphoryl
akt
fig
occur
rapidli
treatment
produc
sustain
effect
fig
contrast
increas
baselin
phosphoryl
kinas
target
evalu
otherwis
untreat
cell
fig
consist
result
cell
inhibit
degrad
phosphoryl
mapk
human
monocyt
also
stimul
akt
phosphoryl
fig
cell
phosphoryl
akt
block
specif
inhibitor
implic
pathway
mediat
effect
fig
known
neg
regul
mapk
pathway
inhibit
gene
express
cell
consist
resveratrol
inhibit
secret
cell
stimul
pathway
accompani
inhibit
jnk
mapk
inhibit
pathway
increas
mortal
circul
proinflammatori
cytokin
level
endotoxem
mice
well
mice
polymicrobi
sepsi
induc
cecal
ligat
punctur
addit
glucan
phosphat
protect
mice
cecal
ligat
punctur
model
increas
tissu
activ
kidney
lung
heart
correl
surviv
anim
interestingli
human
human
stimul
express
secret
proinflammatori
cytokin
human
conjunctiv
epitheli
cell
accompani
phosphoryl
akt
known
regul
cellular
respons
pathway
human
neutrophil
peptid
induc
signal
pathway
receptor
human
induc
chemotaxi
monocyt
receptor
induc
chemotaxi
dendrit
cell
receptor
date
report
receptor
nevertheless
studi
underway
identifi
target
upstream
pathway
relationship
pakt
downstream
signal
pathway
suppress
secret
extrem
rapid
suggest
may
also
regul
pathway
distinct
involv
signal
express
proinflammatori
gene
sempl
et
al
demonstr
properti
exampl
human
inhibit
gene
transcript
proinflammatori
cytokin
secret
mous
macrophag
via
inhibit
pathway
involv
signal
trif
suggest
contrast
proinflammatori
properti
report
may
reflect
differ
structur
featur
andor
puriti
peptid
prepar
anoth
possibl
suggest
other
proinflammatori
vs
properti
singl
peptid
may
function
local
concentr
context
specul
express
high
level
granul
circul
neutrophil
monocyt
provid
physiolog
dampen
inflammatori
process
follow
releas
andor
secret
system
local
summari
suppress
activ
cytokin
express
releas
immunomodul
occur
tlr
tnf
pathway
evid
role
induct
akt
phosphoryl
suggest
pakt
cell
immunomodulatori
properti
macrocycl
peptid
distinct
human
appear
suppress
inflamm
mechan
distinct
human
relat
differenti
inhibit
tnf
secret
stimul
blood
cell
propos
isoform
may
uniqu
tool
dissect
regulatori
pathway
determin
whether
host
respons
inflammatori
stimuli
result
health
diseas
pt
kkt
design
perform
experi
jb
dt
produc
analyz
provid
reagent
pt
ajo
psg
me
analyz
data
wrote
manuscript
author
declar
compet
financi
interest
